Click2PrintAE®, an end-to-end digital workflow for 3D printed ocular prosthetics

Click2PrintAE®，3D 打印义眼的端到端数字工作流程

• 批准号: 10071306
• 金额: $ 26.45万
• 依托单位: OCUPEYE LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10071306
• 关键词: Click2PrintAE; end; digital; workflow; 3D

Incorporated in 2016, Ocupeye are a UK-based SME with an innovative, visionary team of assistive devices innovators led by design, engineering, and business experts. Our strong ambition to drive positive change within the healthcare industry has led us on a journey to create a 3D printing process for prosthetic eyes that not only reduces hospital costs and labour time, but prioritises patient comfort, satisfaction, and prosthetic fit.Over 8 million people worldwide and 70k in the UK wear a prosthetic eye \[Moorfields Eye Charity\]. Despite technological advancements elsewhere in healthcare, the current process to supply ocular prosthetics to patients has remained largely unchanged for over 70 years, with ocular prosthetics currently moulded, shaped, painted, and fitted individually by hand with techniques from the 1950s. The process is invasive and often traumatic for patients, particularly for children, with alginate injections required to make wax patterns for patient's eye shapes. Prosthetics are then hand-painted, assembled, and polished, which is time-consuming and requires highly skilled resource. Waiting list time been exacerbated by COVID-19, with waiting list numbers for elective care increased from 4.4 million to 6 million people \[NHS Delivery Plan\]. This greatly impacts patient care, satisfaction, and overall quality of life.To address these issues, Ocupeye will bring to market the world's first end-to-end digital process for the 3D printing and manufacture of prosthetic eyes. The process will be non-invasive and no-touch to patients and significantly reduce the extortionate waiting list time from 60 weeks to a 3-week turnaround, whilst delivering a much-needed, innovative life sciences product into healthcare more quickly and effectively.

Ocupeye成立于2016年，是一家总部位于英国的中小企业，拥有一支由设计、工程和商业专家领导的创新、有远见的辅助设备创新者团队。我们在医疗保健行业推动积极变革的雄心壮志使我们踏上了为假眼创建3D打印工艺的旅程，这不仅降低了医院成本和劳动时间，而且优先考虑了患者的舒适度、满意度和假眼的契合度。全世界有超过800万人，英国有7万人戴着假眼\[Moorfields Eye Charity\]。尽管医疗保健领域的技术进步，但目前为患者提供眼假体的工艺在70多年来基本保持不变，目前的眼假体是用20世纪50年代的技术手工制作、成型、涂漆和安装的。这个过程是侵入性的，对病人来说往往是创伤性的，尤其是对儿童，需要注射海藻酸盐来制作病人眼睛形状的蜡样。然后手工绘制，组装和抛光假肢，这是耗时的，需要高度熟练的资源。COVID-19加剧了等候名单的时间，选择性护理的等候名单人数从440万人增加到600万人\[NHS Delivery Plan\]。这极大地影响了患者的护理、满意度和整体生活质量。为了解决这些问题，Ocupeye将向市场推出世界上第一个用于3D打印和制造假眼的端到端数字流程。该过程将是非侵入性和非接触式的，并显着减少了高昂的等待时间，从60周到3周的周转时间，同时更快速有效地为医疗保健行业提供急需的创新生命科学产品。